Literature DB >> 2872268

The effect of protein II and pili on the interaction of Neisseria gonorrhoeae with human polymorphonuclear leucocytes.

M Virji, J E Heckels.   

Abstract

Colonial variants of Neisseria gonorrhoeae strain P9 expressing different pili and/or outer membrane protein II (P.II) were investigated with respect to their interaction with human polymorphonuclear leucocytes (PMN). Two assay systems were used. A phagocytic killing assay measured the intracellular survival of gonococci, and PMN chemiluminescence (CL) was used to determine the initial surface interactions. All variants expressing P.II were killed effectively by PMN and also greatly stimulated PMN CL. The P.II- variants, on the other hand, were resistant to phagocytic killing and stimulated a much lower CL response. The presence of different P.II species was associated with different CL profiles and therefore different modes of interaction with the PMN membrane. A P.II-specific monoclonal IgG was opsonic and greatly increased PMN CL in contrast to F(ab')2 prepared from the same antibody, which inhibited it, thus confirming the role of P.II in the PMN interaction. Phagocytic killing assays revealed that with the loss of P.II, gonococcal variants acquired resistance to killing. Comparison of piliated and non-piliated pairs of variants with the same P.II profile showed that PMN-gonococcal interactions are dominated by the nature of the P.II species present whereas pili have little effect.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872268     DOI: 10.1099/00221287-132-2-503

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  60 in total

Review 1.  A bacterial siren song: intimate interactions between Neisseria and neutrophils.

Authors:  Alison K Criss; H Steven Seifert
Journal:  Nat Rev Microbiol       Date:  2012-01-31       Impact factor: 60.633

2.  Monoclonal antibodies to outer membrane protein PII block interactions of Neisseria gonorrhoeae with human neutrophils.

Authors:  C Elkins; R F Rest
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

Review 3.  Genetic mechanisms and biological implications of phase variation in pathogenic neisseriae.

Authors:  T F Meyer; J P van Putten
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

4.  Defining the roles of human carcinoembryonic antigen-related cellular adhesion molecules during neutrophil responses to Neisseria gonorrhoeae.

Authors:  Helen Sarantis; Scott D Gray-Owen
Journal:  Infect Immun       Date:  2011-11-07       Impact factor: 3.441

5.  Anaerobic growth of gonococci does not alter their Opa-mediated interactions with human neutrophils.

Authors:  J V Frangipane; R F Rest
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

Review 6.  Mucosal infection with Neisseria gonorrhoeae. Bacterial adaptation and mucosal defenses.

Authors:  M S Cohen; P F Sparling
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

7.  Interactions of Neisseria gonorrhoeae with human neutrophils: studies with purified PII (Opa) outer membrane proteins and synthetic Opa peptides.

Authors:  F L Naids; B Belisle; N Lee; R F Rest
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

8.  Resistance of Neisseria gonorrhoeae to non-oxidative killing by adherent human polymorphonuclear leucocytes.

Authors:  Alison K Criss; Ben Z Katz; H Steven Seifert
Journal:  Cell Microbiol       Date:  2009-03-12       Impact factor: 3.715

9.  Growth of Neisseria gonorrhoeae in CMP-N-acetylneuraminic acid inhibits nonopsonic (opacity-associated outer membrane protein-mediated) interactions with human neutrophils.

Authors:  R F Rest; J V Frangipane
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

10.  Regulation of catalase in Neisseria gonorrhoeae. Effects of oxidant stress and exposure to human neutrophils.

Authors:  H Y Zheng; D J Hassett; K Bean; M S Cohen
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.